Exclusive-Novo Nordisk India execs urge early Wegovy launch

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a ...
Doctors say early obesity intervention can help prevent later health problems. But prescribing GLP-1s, such as Ozempic and ...
Yet at the annual meeting of the Menopause Society earlier this fall, researchers presented new evidence that hormone therapy ...
Defiance ETFs introduces NVOX, a leveraged ETF offering 2X exposure to Novo Nordisk's stock price movements, targeting the ...
Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk ...
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial ...
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its ...
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...